These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 1281713

  • 41. Glutamatergic neurotransmission is not essential for, but plays a modulatory role in, the production of gasping in arterially-perfused adult rat.
    Warren KA, Solomon IC.
    Adv Exp Med Biol; 2008; 605():423-7. PubMed ID: 18085311
    [Abstract] [Full Text] [Related]

  • 42. [Role of neuroexcitatory amino acids in memory processes. Study with gamma-L-glutamyl-L-aspartic acid].
    Ungerer A, Mathis C, Melan C, De Barry J.
    Encephale; 1990; 16(6):423-9. PubMed ID: 1983215
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Schedule-controlled behavioral effects of the selective 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic acid antagonist LY293558 in pigeons.
    Benvenga MJ, Ornstein PL, Leander JD.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):164-70. PubMed ID: 7562545
    [Abstract] [Full Text] [Related]

  • 46. [Stimulating chemical transmitter systems in the brain].
    Herrling PL.
    Schweiz Arch Neurol Psychiatr (1985); 1986 Oct; 137(5):41-57. PubMed ID: 2431472
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. N-methyl-D-aspartate antagonists: ready for clinical trial in brain ischemia?
    Albers GW, Goldberg MP, Choi DW.
    Ann Neurol; 1989 Apr; 25(4):398-403. PubMed ID: 2565699
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
    Pittaluga A, Raiteri M.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):232-7. PubMed ID: 1370540
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Aspartate and glutamate as synaptic transmitters of parallel visual cortical pathways.
    Hicks TP, Ruwe WD, Veale WL, Veenhuizen J.
    Exp Brain Res; 1985 Jan; 58(2):421-5. PubMed ID: 2860000
    [Abstract] [Full Text] [Related]

  • 56. The transmitter role of glutamate in nervous systems.
    Takeuchi A.
    Jpn J Physiol; 1987 Jan; 37(4):559-72. PubMed ID: 2892957
    [Abstract] [Full Text] [Related]

  • 57. Excitatory amino acids and neuropsychiatric disorders.
    Olney JW.
    Biol Psychiatry; 1989 Sep; 26(5):505-25. PubMed ID: 2571362
    [No Abstract] [Full Text] [Related]

  • 58. Modulatory role of GABA receptor subtypes and glutamate receptors in the anticonvulsant effect of barbiturates.
    Ticku MK, Kulkarni SK, Mehta AK.
    Epilepsy Res Suppl; 1992 Sep; 8():57-62. PubMed ID: 1358104
    [No Abstract] [Full Text] [Related]

  • 59. Aspartate and glutamate as possible neurotransmitters of cells in layer 6 of the visual cortex.
    Baughman RW, Gilbert CD.
    Nature; 1980 Oct 30; 287(5785):848-50. PubMed ID: 6107858
    [Abstract] [Full Text] [Related]

  • 60. Effect of beta-N-oxalyl-L-alpha, beta-diaminopropionic acid on glutamate uptake by synaptosomes.
    Lakshmanan J, Padmanaban G.
    Nature; 1974 May 31; 249(456):469-71. PubMed ID: 4209717
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.